Non-pharmacological interventions play a big role in managing rheumatoid arthritis (RA) symptoms and improving quality of ...

The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first ...

Efforts to more precisely select appropriate therapy for individual patients with rheumatoid arthritis have not yet yielded a ...

But what if nature itself offers something even better—without having to open the medicine cabinet? In the search for natural ...

A rheumatologist discusses how her understanding of chronic pain in PsA has evolved—and how it affects her approach to ...

Researchers have uncovered multiple new genes and genetic pathways that could lead to repurposing hundreds of existing drugs ...

Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with ...

It had been hoped that RA patients might actually benefit more from these drugs, known as immune checkpoint inhibitors (ICIs) ...